tiprankstipranks
Trending News
More News >
ProMIS Neurosciences (PMN)
NASDAQ:PMN
Advertisement

ProMIS Neurosciences (PMN) Stock Statistics & Valuation Metrics

Compare
158 Followers

Total Valuation

ProMIS Neurosciences has a market cap or net worth of $25.21M. The enterprise value is $21.06M.
Market Cap$25.21M
Enterprise Value$21.06M

Share Statistics

ProMIS Neurosciences has 32,689,190 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,689,190
Owned by Insiders
Owned by Institutions

Financial Efficiency

ProMIS Neurosciences’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is -100805.41%.
Return on Equity (ROE)0.17
Return on Assets (ROA)146.94
Return on Invested Capital (ROIC)-100805.41%
Return on Capital Employed (ROCE)-1.01K
Revenue Per Employee0.00
Profits Per Employee396.98K
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio
PS Ratio0.00
PB Ratio3.31
Price to Fair Value<0.01
Price to FCF-1.35
Price to Operating Cash Flow-1.48
PEG Ratio0.17

Income Statement

In the last 12 months, ProMIS Neurosciences had revenue of 0.00 and earned 2.78B in profits. Earnings per share was 0.11.
Revenue0.00
Gross Profit0.00
Operating Income-16.83B
Pretax Income2.78B
Net Income2.78B
EBITDA-16.83B
Earnings Per Share (EPS)0.11

Cash Flow

In the last 12 months, operating cash flow was ― and capital expenditures 0.00, giving a free cash flow of ― billion.
Operating Cash Flow
Free Cash Flow
Free Cash Flow per Share0.00

Dividends & Yields

ProMIS Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.84
52-Week Price Change-46.53%
50-Day Moving Average0.55
200-Day Moving Average0.77
Relative Strength Index (RSI)55.22
Average Volume (3m)14.26M

Important Dates

ProMIS Neurosciences upcoming earnings date is Aug 18, 2025, Before Open (Confirmed).
Last Earnings DateMay 12, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date

Financial Position

ProMIS Neurosciences as a current ratio of 8.52, with Debt / Equity ratio of 0.00%
Current Ratio8.52
Quick Ratio8.52
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio219.18

Taxes

In the past 12 months, ProMIS Neurosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

ProMIS Neurosciences EV to EBITDA ratio is >-0.01, with an EV/FCF ratio of -0.41.
EV to Sales0.00
EV to EBITDA>-0.01
EV to Free Cash Flow-0.41
EV to Operating Cash Flow-0.41

Balance Sheet

ProMIS Neurosciences has $8.40M in cash and marketable securities with C$0.00 in debt, giving a net cash position of -$8.40M billion.
Cash & Marketable Securities$8.40M
Total DebtC$0.00
Net Cash-$8.40M
Net Cash Per Share-$0.26
Tangible Book Value Per Share$0.64

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for ProMIS Neurosciences is $5.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$5.00
Price Target Upside549.35% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast
EPS Growth Forecast98.61%

Scores

Smart Score5
AI Score37.5
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis